Prediction 1: Psychedelics Alleviate Anosognosia¶

Administration of psychedelic substances at sub-ego-dissolution doses to patients with anosognosia should produce a measurable, dose-dependent, temporary increase in explicit awareness of their deficits.

This is a cross-domain surprise prediction -- it connects psychopharmacology and clinical neurology through a single principle in a way that no other consciousness framework generates. No competing theory predicts that a psychedelic should help an anosognosia patient recognize their paralysis.

The Mechanism: Permeability as a Two-Way Street¶

The prediction rests on the interaction of two phenomena that the Four-Model Theory explains through the same mechanism operating in opposite directions:

Anosognosia is a local decrease in implicit-explicit permeability. The ISM registers the deficit -- the body schema contains accurate information about the paralysis, the proprioceptive loss, or the visual field cut. But the transfer of this specific information to the ESM is blocked. The patient's substrate knows about the deficit; the patient's conscious self-model does not. The result is the characteristic clinical picture: a hemiplegic patient who sincerely denies being paralyzed, or a cortically blind patient who insists they can see.

Psychedelics globally increase permeability, as described in the theory's account of psychedelic phenomenology. They weaken the implicit-explicit boundary across the board, allowing normally unconscious processing stages to reach the conscious simulation.

The prediction follows directly: if anosognosia is a local permeability block, and psychedelics produce a global permeability increase, then the global increase should compensate for the local block -- allowing deficit information to reach the ESM. The patient should, temporarily and dose-dependently, become aware of their condition.

Figure¶

graph LR
    subgraph "Anosognosia — Local Block"
        ISM_A["ISM\nRegisters deficit\n(paralysis, blindness)"]
        BLOCK["Local Permeability\nBlock"]
        ESM_A["ESM\n'I am fine'\n(deficit denied)"]
        ISM_A -->|"deficit info"| BLOCK
        BLOCK -.->|"❌ blocked"| ESM_A
    end

    subgraph "Psychedelic Intervention"
        PSY["Psilocybin\n(sub-ego-dissolution dose)"]
        GLOBAL["Global Permeability\nIncrease"]
        PSY -->|"increases"| GLOBAL
    end

    subgraph "Predicted Outcome"
        ISM_B["ISM\nRegisters deficit"]
        COMP["Local block\ncompensated by\nglobal increase"]
        ESM_B["ESM\n'I am paralyzed'\n(deficit recognized)"]
        ISM_B -->|"deficit info"| COMP
        COMP -->|"✓ reaches ESM"| ESM_B
    end

    GLOBAL -->|"compensates for"| COMP

    style BLOCK fill:#F44336,stroke:#333,color:#fff
    style COMP fill:#4CAF50,stroke:#333,color:#fff
    style ESM_A fill:#FF9800,stroke:#333,color:#fff
    style ESM_B fill:#4CAF50,stroke:#333,color:#fff
    style PSY fill:#9C27B0,stroke:#333,color:#fff

Anosognosia as a local permeability block (left) compensated by global psychedelic-induced permeability increase (center), producing temporary deficit awareness (right). The ISM contains accurate information throughout -- the bottleneck is transfer to the ESM.

Testability¶

The prediction is specific enough for clinical investigation:

Measurable outcome: Improvement in explicit awareness, quantifiable via established anosognosia assessment scales.
Dose-dependent: Higher sub-ego-dissolution doses should produce greater improvement, up to the threshold where ego dissolution itself introduces confounding effects.
Temporary: The effect should dissipate as the psychedelic clears the system, since the local permeability block is structural (lesion-based), not pharmacological.
EEG correlate: Improvement should correlate with EEG complexity increases over the lesioned hemisphere specifically, as the global permeability increase reaches the damaged region.
Safety: Psilocybin clinical trials already have extensive safety data at the relevant dose ranges, making initial case studies feasible within existing regulatory frameworks.

Falsification Conditions¶

The prediction specifies clear falsification criteria. If psychedelics increase global neural complexity without improving explicit awareness in anosognosia patients, the variable-permeability model is incomplete -- global permeability increase does not interact with local blocks as predicted. If the effect occurs but is not dose-dependent, the mechanism is different from what the theory proposes.

Distinguishing Power¶

IIT, GNW, HOT, predictive processing, and AST are all silent on why a psychedelic should help an anosognosia patient. This is not because they are wrong about other things -- it is because they lack the specific architectural feature (variable permeability of a defined boundary) that generates this cross-domain connection. The prediction is a direct consequence of the theory's architecture, not an ad hoc addition.

Key Takeaway¶

Prediction 1 connects two clinically distinct phenomena -- psychedelic experience and anosognostic denial -- through the single principle of variable permeability operating in opposite directions. No other consciousness theory generates this cross-domain prediction, making it a distinctive empirical test of the Four-Model Theory.